Ajanta Pharma USA Inc recalls Ranolazine Extended-Release Tablets
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Failed Dissolution Specifications: below specification
- Products
-
- Ranolazine Extended-Release Tablets
- Company
- Ajanta Pharma USA Inc
- Where it was sold
-
Nationwide in the US.
Nationwide
- About this recall
- Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807. NDC: 27241-126-02